In this issue:
A culturally informed model of care for Indigenous patients with ACS
Lipoprotein(a) levels and cardiovascular risk reduction with icosapent ethyl
Exercise therapy for chronic symptomatic peripheral artery disease
Uniform or sex-specific cardiac troponin thresholds to rule out MI?
Extended clopidogrel monotherapy vs DAPT in high-risk patients with ACS
Beta-blocker use post-MI in patients with preserved ejection fraction
Antihypertensive drug therapy and risk of dementia in the elderly
Effects of statin therapy on new-onset diabetes and worsening glycaemia
Efficacy and safety of dapagliflozin in patients with acute HF
Preventive PCI for vulnerable atherosclerotic coronary plaques
Please login below to download this issue (PDF)